Day One Biopharmaceuticals Inc banner
D

Day One Biopharmaceuticals Inc
NASDAQ:DAWN

Watchlist Manager
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Watchlist
Price: 10.43 USD -2.89% Market Closed
Market Cap: $1.1B

Intrinsic Value

The intrinsic value of one DAWN stock under the Base Case scenario is 10.82 USD. Compared to the current market price of 10.43 USD, Day One Biopharmaceuticals Inc is Undervalued by 4%.

DAWN Intrinsic Value
10.82 USD
Undervaluation 4%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation History
Day One Biopharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about DAWN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is DAWN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Day One Biopharmaceuticals Inc.

Explain Valuation
Compare DAWN to

Fundamental Analysis

How do you feel about DAWN?
Bearish
Neutral
Bullish
Financials
Efficiency

Earnings Waterfall
Day One Biopharmaceuticals Inc

Wall St
Price Targets

DAWN Price Targets Summary
Day One Biopharmaceuticals Inc

Wall Street analysts forecast DAWN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DAWN is 23.12 USD with a low forecast of 17.17 USD and a high forecast of 30.45 USD.

Lowest
Price Target
17.17 USD
65% Upside
Average
Price Target
23.12 USD
122% Upside
Highest
Price Target
30.45 USD
192% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Day One Biopharmaceuticals Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

DAWN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one DAWN stock?

The intrinsic value of one DAWN stock under the Base Case scenario is 10.82 USD.

Is DAWN stock undervalued or overvalued?

Compared to the current market price of 10.43 USD, Day One Biopharmaceuticals Inc is Undervalued by 4%.

Back to Top